RE:RE:RE:RE:RE:RE:RE:RE:RE:Clinical Trial Size in Orphan and Rare Diseases yes marvellous.. Fast Track designation, which means shortened lead time for assessment of a BLA... they need a successful Phase III, before they even write said dossier... so having ODD without an approval is meaningless. Like I said, Not nonsense, FACT